Denver, CO – (NewMediaWire) – October 12, 2021 – CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (“CBD Global” or the “Company”), is pleased to share that it is adding new brands to its growing distribution channel.
Legacy Distribution Group, “Legacy Distribution” (Denver, CO) is one of the country’s first CBD-focused Direct Store Delivery (DSD) distributors. CBD Global Sciences’ Legacy Distribution Group is excited to announce the addition of Gorilla Hemp to its family of brands. Legacy will be carrying the Gorilla Hemp line and expects it to be a very successful product in their portfolio.
Brad Wyatt, CEO of CBD Global Sciences, shared, “I am excited to see the interest from multiple large and successful CBD infused brands like Gorilla Hemp. Gorilla Hemp is trailblazing the energy drink space that combines ingredients that boost physical stamina and mental clarity with the wellness effects of 20mg of CBD. They are proving to be an innovator in the space with health and performance at mind for its consumers. We look forward to adding to their total points of distribution with Legacy Distribution.”
ABOUT GORILLA HEMP
Elegance Brands recently entered the U.S. market via their first exclusive distribution deal with KC distributing in Texas for Gorilla Hemp, a nonalcoholic, CBD-based energy drink. According to the company, this energy drink “combines ingredients that boost physical stamina and mental clarity with the wellness effects of 20mg Hemp CBD, delivering a balanced experience that optimizes performance throughout the day.” Gorilla Hemp is a carbonated beverage that contains a unique combination of functional ingredients, including 20mg Hemp CBD isolate, 160mg green coffee caffeine, and natural plant extracts. Their proprietary formulation was designed to optimize both mental and physical performance, while providing balance and other wellness benefits associated with CBD. Harnessing the best ingredients nature has to offer, Gorilla Hemp provides maximum energy alongside mental clarity. Guarana, green coffee caffeine, and B vitamins provide a stimulating effect, while ginseng and gingko biloba improve brain function with their antioxidant properties. The addition of high-quality hemp CBD isolate gives balance to the blend and helps speed recovery times with its anti-inflammatory qualities.
ABOUT CBD GLOBAL SCIENCES INC.
CBD Global Sciences, Inc., is a hemp-based CBD producer and branding investment vehicle which currently owns two brands, branded under the name Aethics™ (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, Hydration products and Confectionary products. CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.
CBD Global Sciences, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC (www.resinosa.com) and Legacy Distribution Group, (www.legacydistributiongroup.com), is delivering quality CBD products both in a retail and e-commerce formats nationwide. The Direct Store Delivery (DSD) provides distribution services for multiple vendors of CBD infused products and non-CBD products throughout the Colorado and Wyoming territories that are currently servicing over 750 C-store and large box retailers with expansion plans to exceed 5,000 stores in the next 12-24 months. With the soon to be added manufacturing division, Resinosa LLC, it will have the capabilities to provide cGMP manufacturing to the CBD industry with both private label and white label CBD and non-CBD product lines.
For further information, please contact Investor Relations, (888) 401-2239, firstname.lastname@example.org
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; and delay or failure to receive board, shareholder, or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.